NCT04144101View on ClinicalTrials.gov

Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Etoricoxib

Etoricoxib 60 mg QD Oral

DRUG

Aceclofenac

Aceclofenac 100 mg BID Oral

All Listed Sponsors
lead

Chung Shan Medical University

OTHER

NCT04144101 - Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter